Medigene AG (WBO:MDG2)
€ 1.1 0.026 (2.42%) Market Cap: 16.06 Mil Enterprise Value: 4.58 Mil PE Ratio: 0 PB Ratio: 0.85 GF Score: 46/100

Q4 2022 Medigene AG Earnings Call Transcript

Mar 29, 2023 / 01:00PM GMT
Release Date Price: €3.61 (-2.31%)
Operator

Welcome to the Medigene Full Year 2022 Earnings Conference Call. (Operator Instructions) Please note, this conference is being recorded.

I would now like to hand over to your speaker today, Ms. Pamela Keck, Head of IR and Corporate Communications. Please go ahead.

Pamela Keck
Medigene AG - VP of IR & Corporate Communications

Welcome, everyone, and thank you for joining us. With me today is Dr. Selwyn Ho, CEO of Medigene. Today, we announced financial results for the year ended December 31, 2022. You can access the press release on the Investor Relations page of our website at medigene.com.

Before we get started, let's quickly run through the forward-looking statements. Please note that as part of our discussion today, management will be making forward-looking statements. Also, we believe our expectations are based on reasonable assumptions. By their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot